Sysmex Corporation and Hologen have established Saibogen, an joint artificial intelligence (AI)-based venture aimed at generating clinical intelligence from routine blood examinations.
The newly formed entity will apply generative AI (genAI) models to diagnostic information produced by Sysmex haematology hardware, with its initial commercial products planned exclusively for research use.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Saibogen will deliver its software directly through Sysmex’s haematology analysers, eliminating the need for laboratories to purchase additional instruments, chemical reagents, or patient samples, the companies stated.
The platform combines Sysmex test data with Hologen’s large medicine models, genAI systems that are configured to analyse biological mechanisms within real-world healthcare datasets.
Menawhile, under the platform, the companies intends to convert standard laboratory equipment into analytical platforms that provide biological information without reducing test accessibility, assisting healthcare providers with predictive, preventive, and personalised patient care.
Haematology testing is among the most widely conducted medical laboratory assessments globally, frequently serving as the initial evaluation in patient healthcare pathways.
Sysmex analysers process around three billion of these tests annually, generating standardised metrics for clinical professionals across international healthcare systems.
Saibogen intends to identify biological indicators within this existing flow of testing data to offer new analytical findings to clinical researchers and healthcare practitioners.
Saibogen CEO Leila Luheshi said: “Every routine blood count measures tens of thousands of cells with remarkable precision, and much of that information goes unused.
“We are building the AI to read it in full, so researchers, laboratories and clinicians can learn far more from a test that is already part of everyday care.”
Sysmex, based in Kobe, Japan, contributes haematology technical knowledge, proprietary datasets, diagnostic product development, and an established worldwide distribution network.
UK-based Hologen provides over 10 years of fundamental scientific research conducted by its co-founders into medical AI deployment.
